Friday, July 10, 2026
🇺🇸 FDA

pharma · Ulcerative Colitis · Diabetes Mellitus, Type 2

Eli Lilly and

Eli Lilly and Company

Eli Lilly and trial registry — 64 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
Lilly Corporate Center, Indianapolis, Indiana 46285, US HQ
55,860 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Lilly Corporate Center, Indianapolis, Indiana 46285, US
Employees
55,860
Programs
62
Drugs
42
Patents
0
Official website ↗ All projects Drug pipeline News & analysis
Intelligence · Clinical Trials

Eli Lilly and clinical trials

Registry index of 64 ClinicalTrials.gov studies linked to Eli Lilly and programs — each row shows trial ID, program name, phase, status, and indication.

Eli Lilly and trial registry — 64 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Eli Lilly and.

  1. premeal insulin lispro mixtures — Approved

    Clinical update

  2. Pemetrexed — Phase 3

    Clinical update

  3. pemetrexed — Phase 3

    Clinical update

  4. Orforglipron — Phase 3

    Clinical update

  5. Mirikizumab - Intravenous (IV) — Phase 2

    Clinical update

  6. LY3209590 (SC) — Phase 1

    Clinical update

  7. Insulin lispro low mixture — Approved

    Clinical update

  8. Insulin Glargine — Approved

    Clinical update

Trial registry

64 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.